A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes : The EPIC-InterAct case-cohort study

Fumiaki Imamura,Stephen J. Sharp,Albert Koulman,Matthias B. Schulze,Janine Kröger,Julian L. Griffin,José María Huerta,Marcela Guevara,Ivonne Sluijs,Antonio Agudo,Eva Ardanaz,Beverley Balkau,Heiner Boeing,Veronique Chajes,Christina C. Dahm,Courtney Dow,Guy Fagherazzi,Edith J. M. Feskens,Paul W. Franks,Diana Gavrila,Marc J. Gunter,Rudolf Kaaks,Timothy J. Key,Kay-Tee Khaw,Tilman Kühn,Olle Melander,Elena Molina-Portillo,Peter Nilsson,Anja Olsen,Kim Overvad,Domenico Palli,Salvatore Panico,Olov Rolandsson,Sabina Sieri,Carlotta Sacerdote,Nadia Slimani,Annemieke M.W. Spijkerman,Anne Tjønneland,Rosario Tumino,Yvonne T. van der Schouw,Claudia Langenberg,Elio Riboli,Nita G. Forouhi,Nicholas J. Wareham

A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes : The EPIC-InterAct case-cohort study

2017

Background Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) ...

Keywords:

EPIC
Phospholipid
Type 2 diabetes
Prospective cohort study
Insulin resistance
Cohort study
Linoleic acid
Biochemistry
Carbohydrate metabolism
Medicine
Endocrinology
Internal medicine
Diabetes mellitus
Case-control study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations